Literature DB >> 17267878

Meningioma mimicking puerperal psychosis.

Su-Yen Khong1, John Leach, Catherine Greenwood.   

Abstract

BACKGROUND: Meningiomas are slow-growing benign brain tumors. They can be sensitive to sex hormones, increasing in size with pregnancy and leading to clinical presentation either before or immediately after delivery. Initial symptoms and signs can present in the antenatal as well as the postnatal period. CASE: A patient presented with confusion associated with complaints of déjà vu and auditory hallucinations on day 1 postcesarean delivery. Meningioma was diagnosed by computed tomography and treated successfully with steroids, anticonvulsant, and craniotomy.
CONCLUSION: It is imperative to perform a thorough neurologic examination in a patient who presents with atypical psychiatric symptoms in the antenatal or postpartum period. Neuroimaging should be performed in the presence of any neurologic abnormality to exclude intracranial lesions such as meningioma.

Entities:  

Mesh:

Year:  2007        PMID: 17267878     DOI: 10.1097/01.AOG.0000226856.21741.3f

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  3 in total

1.  Why in the age of CT scans and MRIs is a brain tumour mistaken for a psychiatric illness?

Authors:  Riccardo Caruso; Antonio Piro
Journal:  BMJ Case Rep       Date:  2017-10-04

Review 2.  Unique features of pregnancy-related meningiomas: lessons learned from 148 reported cases and theoretical implications of a prolactin modulated pathogenesis.

Authors:  Yosef Laviv; Victoria Ohla; Ekkehard M Kasper
Journal:  Neurosurg Rev       Date:  2016-06-16       Impact factor: 3.042

3.  A pregnant female with a large intracranial mass: Reviewing the evidence to obtain management guidelines for intracranial meningiomas during pregnancy.

Authors:  Ekkehard M Kasper; Philip E Hess; Michelle Silasi; Kee-Hak Lim; James Gray; Hasini Reddy; Lauren Gilmore; Burkhard Kasper
Journal:  Surg Neurol Int       Date:  2010-12-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.